Showing results (231-240 of 26,838) with videos related to
Sort By:
Pageof 2,684
The Journal of Biological Chemistry|July 3, 2010
Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cellsYoung Jin Jeon, Kun Yeong Lee, Yong-Yeon Cho, et al.Ebiomedicine|February 6, 2018
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing TetraploidizationYiu To Yeung, Shuying Yin, Bingbing Lu, et al.Journal of Cellular and Molecular Medicine|May 13, 2021
Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivoMan Zhang, Rui Wang, Jie Tian, et al.Cancer Research|September 19, 2007
Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformationKe Yao, Yong-Yeon Cho, H Robert Bergen, et al.Journal of Experimental & Clinical Cancer Research : CR|November 28, 2018
MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignanceShan Zhou, Jinping Lu, Yuejin Li, et al.Biochemical Pharmacology|January 19, 2023
Orobol, 3'-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCCEunmiri Roh, Jong-Eun Kim, Tianshun Zhang, et al.Journal of Cancer|June 7, 2021
Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived XenograftsFayang Ma, Kyle Laster, Wenna Nie, et al.International Journal of Oncology|December 1, 2022
Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLCYang Yang, Xiaoli Zheng, Peizan Ni, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2019
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell CarcinomaFeifei Liu, Xueyin Zu, Xiaomeng Xie, et al.Cellular and Molecular Life Sciences : CMLS|August 30, 2023
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancerXiaomeng Xie, Kyle Vaughn Laster, Jian Li, et al.Pageof 2,684